LIPOPROTEIN (A) LEVELS IN MONOGENIC VERSUS POLYGENIC HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Jain, A. [1 ]
Ewang-Emukowhate, M. [1 ]
Hoshi, N. [1 ]
Omosilade, M. [1 ]
Nair, D. R. [1 ]
机构：
[1] Royal Free Hosp, Dept Clin Biochem, Pond St, London NW32QG, England
来源：
ATHEROSCLEROSIS PLUS | 2021年 / 43卷
关键词：
Polygenic Hypercholesterolemia; Lipoprotein (a); Familial hypercholesterolemia;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
  • [1] Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically
    Wang, Jian
    Dron, Jacqueline S.
    Ban, Matthew R.
    Robinson, John F.
    McIntyre, Adam D.
    Alazzam, Maher
    Zhao, Pei Jun
    Dilliott, Allison A.
    Cao, Henian
    Huff, Murray W.
    Rhainds, David
    Low-Kam, Cecile
    Dube, Marie-Pierre
    Lettre, Guillaume
    Tardif, Jean-Claude
    Hegele, Robert A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (12) : 2439 - 2445
  • [2] Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
    Mickiewicz, Agnieszka
    Futema, Marta
    Cwiklinska, Agnieszka
    Kuchta, Agnieszka
    Jankowski, Maciej
    Kaszubowski, Mariusz
    Chmara, Magdalena
    Wasag, Bartosz
    Fijalkowski, Marcin
    Jaguszewski, Milosz
    Humphries, Steve E.
    Gruchala, Marcin
    LIFE-BASEL, 2020, 10 (05):
  • [3] The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
    Fistra Janrio Tandirerung
    Current Cardiology Reports, 2022, 24 : 1669 - 1677
  • [4] Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
    Jacob, Erin
    Hegele, Robert A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (06) : 419 - 426
  • [5] Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?
    Erin Jacob
    Robert A. Hegele
    Current Atherosclerosis Reports, 2022, 24 : 419 - 426
  • [6] The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
    Tandirerung, Fistra Janrio
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (11) : 1669 - 1677
  • [7] Monogenic, polygenic, and oligogenic familial hypercholesterolemia
    Tada, Hayato
    Nohara, Atsushi
    Kawashiri, Masa-aki
    CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (04) : 300 - 306
  • [8] Epidemiology of atherosclerotic cardiovascular disease in polygenic hypercholesterolemia with or without high lipoprotein(a) levels
    Vinci, Pierandrea
    Fiotti, Nicola
    Panizon, Emiliano
    Tosoni, Letizia Maria
    Cerrato, Carla
    Pellicori, Federica
    Pirulli, Alessia
    Altamura, Nicola
    Schincariol, Paolo
    Di Girolamo, Filippo Giorgio
    Biolo, Gianni
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [9] Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
    Sharifi, Mahtab
    Higginson, Elizabeth
    Bos, Sven
    Gallivan, Angela
    Harvey, Darren
    Li, Ka Wah
    Abeysekera, Amali
    Haddon, Angela
    Ashby, Helen
    Shipman, Kate E.
    Cooper, Jackie A.
    Futema, Marta
    van Lennep, Jeanine E. Roeters
    Sijbrands, Eric J. G.
    Labib, Mourad
    Nair, Devaki
    Humphries, Steve E.
    ATHEROSCLEROSIS, 2017, 263 : 405 - 411
  • [10] Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Brandts, Julia
    Dharmayat, Kanika, I
    Ray, Kausik K.
    Vallejo-Vaz, Antonio J.
    CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (03) : 111 - 118
12345